August 16, 2013

Nutrition 21 Leading Developer and Marketer of Nutritional Ingredients

Nutrition 21, LLC, a leading developer and marketer of nutritional ingredients whose health benefits are substantiated by extensive clinical research, comments on novel research published in the August 8, 2013 New England Journal of Medicine (NEJM) that suggest higher glucose levels may be a risk factor for dementia, even among persons without diabetes.

more news

MORE NEWS
Get in Touch

500 Mamaroneck AveSuite 510Harrison, NY 10528

Nutrition21 Proudly Supports the Following Industry Associations

Association 6050 Uai Nutrition21

©2020 Nutrition21, LLC. All rights reserved.       

Nitrosigine®, Velositol®, nooLVL®, Chromax®, Lepidamax®, Zinmax®, and their associated logos are registered trademarks of Nutrition21, LLC.  All third party trademarks are the property of their respective owners. Nutrition21, LLC's products are protected by a number of patents including, but not limited to: US Patent Nos. 6,809,115; 6,803,456; 7,576,132; 8,062,677; 8,933,022; 9,005,637; 9,028,879; 9,119,835; 9,421,170; 9,597,404; 9,675,702; 10,183,049; 10,245,325; and 10,363,222.

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.